Clinical Trials Browser

Locally Advanced or Metastatic Solid Tumors

Advanced Solid Tumors

Advanced Solid Tumors

Advanced Solid Tumor Cancer

Advanced Solid Tumor Cancer

Solid Tumours

Malignant Solid Tumors

Solid Tumors, Adult

Advanced Solid Tumors

Advanced Solid Tumor

Advanced Malignant Solid Tumor

Advanced Solid Tumors

Rare Malignant Neoplasm

Advanced Solid Tumor

Mesothelioma, Malignant

Metastatic Solid Tumors

Malignant Solid Tumors

Advanced Solid Tumors

HER2+ Advanced Breast Cancer

Advanced Solid Tumors

Advanced Solid Tumor

Advanced Solid Tumor

Malignant Solid Tumor

Mesothelioma, Malignant, Mesothelioma

Advanced Malignant Solid Tumor

Advanced Solid Tumors

Advanced Solid Tumors

Advanced Solid Tumors

Solid Cancers

Solid Tumor, Malignant Ascites

Advanced Solid Tumor

Solid Tumors

Solid Tumors

Solid Tumors

Advanced Solid Tumors

Unresectable Locally Advanced or Metastatic Solid Tumors

Locally Advanced or Metastatic Solid Tumors Harboring KRAS G12C Mutation

Advanced Solid Tumors

Advanced Malignant Solid Tumours

Advanced Solid Tumor

Advanced Solid Tumor

Advanced Solid Tumors

Advanced Solid Tumor

Advanced or Metastatic Solid Tumors

Clinical Trials

BC3195 in Combination With Pembrolizumab in Participants With Locally Advanced or Metastatic Solid Tumors

SKB103 for Injection in Advanced Solid Tumors

A Study to Evaluate Claudin 18.2-Directed ADC LCB02A in Advanced Solid Tumors

Early-phase Trial to Assess the Safety and Preliminary Efficacy of BNT3214 in Adults With Advanced Solid Tumors

A Study to Evaluate Safety, PK and Efficacy of GH55 in Combination With GH21 in Patients With Solid Tumors

PARTHENON

A Study of TAK-505 in Adults With Solid Tumors

A Phase I/Ⅱa Study of HMPL-A580 in Participants With Advanced or Metastatic Solid Tumor

SKB105 for Injection in Advanced Solid Tumors

A Clinical Study of ZL-85FA Tablets

A Study of MHB009C in Patients With Advanced Solid Tumors

A Phase I/II Study to Evaluate XNW34017 in Patients With Advanced or Metastatic Solid Tumor

Rare Tumor Focused Platform Study of Innovative Therapies and Technologies (PLATFORM2)

A Study of SHR-4375 Injection in Combination With Other Antitumor Therapies in Patients With Solid Tumors

Study of TYK-01054 Capsules in Patients With Advanced Solid Tumors

Study of QLC5513 in Combination With Epalolimab Tovolimab (QL1706) ± Platinum in Patients With Advanced or Metastatic Malignant Solid Tumors

Study of ZGGS34 in Participants With Advanced Solid Tumors

Safety and Tolerability of a mRNA Vaccine Encoding Tumor-Specific Circular RNA Antigens in Combination With Anti-PD-1 Monoclonal Antibody in Patients With Advanced Solid Tumors

A Phase I/II Clinical Study of SHR-4298 Injection in Patients With Malignant Solid Tumors

A Clinical Study to Evaluate the Safety of VIB305 in Patients With Advanced Solid Tumors

Chimeric Receptor T Cells With Trastuzumab in HER2+ Advanced Breast Cancer and Other Solid Tumors

A Study of IMM2510 + IMM01 Combination Therapy in Patients With Advanced Solid Tumors

CVL006-T1002

Study of ZG005 in Combination With Gecacitinib and Chemotherapy for Participants With Advanced Solid Tumors

A Phase I/II Clinical Study of FH-006 for Injection in Patients With Malignant Solid Tumors

Study of Iparomlimab and Tuvonralimab Plus Chemotherapy in Malignant Mesothelioma

Phase I/II Study of SCTB39G in Advanced Solid Tumours

NTS071

A Study of QLS5133 Monotherapy in Advanced Solid Tumors

Study of CHO-A04 in Advanced Solid Tumors

A Study to Evaluate the Safety and Tolerability of EP0089

SK-NK Injection in Patients With Advanced Solid Tumors Accompanied by Malignant Ascites

Study of SY-5933 Plus CT-707 in Advanced Solid Tumors With KRAS p.G12C Mutation

Clinical Trial of HRS-4642 Plus SHR-A2102 in Patients With Advanced Solid Tumors

IN10018 Combination Therapy in Previously-treated Solid Tumors

A Clinical Study to Evaluate the Safety, Tolerability, and Efficacy of QLC1101 in Combination With Other Therapies in the Treatment of Patients With Advanced Solid Tumors Harboring a KRAS G12D Mutation

A Clinical Study of 9MW2821 Monotherapy or Combined With Other Anticancer Therapy in Advanced Solid Tumors

A First-in-human Study of KY-0301 in Patients With Advanced Solid Tumors.

Clinical Study of ASN-3186 in Patients with Advanced Solid Tumors

Safety and Efficacy of SYHA1813 Single Agent or in Combination With Different Regimens in Unresectable Locally Advanced or Metastatic Solid Tumors.

GH21 Combined With D-1553 in KRAS G12C Mutant Advanced Solid Tumors

A Phase IB/II Clinical Study of SHR-9839 for Injection Combined With Other Anti-tumor Therapies in Patients With Advanced Solid Tumors

Aims to Explore the Safety, Tolerability, and Preliminary Efficacy of SCTB14 in Adult Patients With Advanced Malignant Solid Tumours.

Study of HS-20105 for Injection in Patients With Advanced Solid Tumors.

A Study of Simmitinib Plus SG001 in Advanced Solid Tumors

A Phase Ib/II Clinical Trial of PE0116 and PE0105 Injection in Treatment of Patients With Advanced Solid Tumor

Study of MHB036C in Participants With Advanced or Metastatic Solid Tumors

Study of MHB088C in Participants With Advanced or Metastatic Solid Tumors